Julio Enrique Serrano Noguès
Direktor/Vorstandsmitglied bei INBEST PRIME II INMUEBLES SOCIMI, S.A.
Aktive Positionen von Julio Enrique Serrano Noguès
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| INBEST PRIME II INMUEBLES SOCIMI, S.A. | Direktor/Vorstandsmitglied | 13.05.2019 | - |
| INBEST PRIME III INMUEBLES SOCIMI, S.A. | Direktor/Vorstandsmitglied | 13.05.2019 | - |
| Palbox Holding Sl | Vorstandsvorsitzender | - | - |
Curapath & Expansion of Drug Delivery Capabilities & Services
 Curapath & Expansion of Drug Delivery Capabilities & Services BiotechnologyHealth Technology Curapath & Expansion of Drug Delivery Capabilities & Services is a GMP-grade manufacturer of polyamino-acid (PAA) based nanoparticle encapsulation technology for advanced drug delivery applications. The company is based in Valencia, Spain. The Spanish company offers contract development and manufacturing services, including preclinical development, analytical characterization, technology transfer, GMP manufacturing, and fill/finish services. The company was founded by Benjumea Isabela Del Alcazar, Maria Jesus VicentDocon. Robert Shaw has been the CEO of the company since 2021. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Julio Enrique Serrano Noguès
Ausbildung von Julio Enrique Serrano Noguès
| University of Valencia | Undergraduate Degree |
Statistik
International
| Spanien | 6 |
Operativ
| Director/Board Member | 3 |
| Undergraduate Degree | 1 |
| Chief Executive Officer | 1 |
Sektoral
| Finance | 3 |
| Consumer Services | 2 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| INBEST PRIME II INMUEBLES SOCIMI, S.A. | Finance |
| INBEST PRIME III INMUEBLES SOCIMI, S.A. | Finance |
| Private Unternehmen | 2 |
|---|---|
| Palbox Holding Sl | |
Curapath & Expansion of Drug Delivery Capabilities & Services
Curapath & Expansion of Drug Delivery Capabilities & Services BiotechnologyHealth Technology Curapath & Expansion of Drug Delivery Capabilities & Services is a GMP-grade manufacturer of polyamino-acid (PAA) based nanoparticle encapsulation technology for advanced drug delivery applications. The company is based in Valencia, Spain. The Spanish company offers contract development and manufacturing services, including preclinical development, analytical characterization, technology transfer, GMP manufacturing, and fill/finish services. The company was founded by Benjumea Isabela Del Alcazar, Maria Jesus VicentDocon. Robert Shaw has been the CEO of the company since 2021. | Health Technology |